心臓カテーテル:医療機器パイプライン分析2017

◆英語タイトル:Cardiac Catheters - Medical Devices Pipeline Assessment, 2017
◆商品コード:GDME0436EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年9月8日
◆ページ数:296
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥896,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,344,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Cardiac Catheters – Medical Devices Pipeline Assessment, 2017
Summary

GlobalData’s Medical Devices sector report, “Cardiac Catheters – Medical Devices Pipeline Assessment, 2017″ provides an overview of Cardiac Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiac Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiac Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiac Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 13
2.1 Cardiac Catheters Overview 13
3 Products under Development 14
3.1 Cardiac Catheters – Pipeline Products by Stage of Development 14
3.2 Cardiac Catheters – Pipeline Products by Segment 15
3.3 Cardiac Catheters – Pipeline Products by Territory 16
3.4 Cardiac Catheters – Pipeline Products by Regulatory Path 17
3.5 Cardiac Catheters – Pipeline Products by Estimated Approval Date 18
3.6 Cardiac Catheters – Ongoing Clinical Trials 19
4 Cardiac Catheters – Pipeline Products under Development by Companies 20
4.1 Cardiac Catheters Companies – Pipeline Products by Stage of Development 20
4.2 Cardiac Catheters – Pipeline Products by Stage of Development 22
5 Cardiac Catheters Companies and Product Overview 24
5.1 3DT Holdings, LLC Company Overview 24
5.1.1 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 24
5.2 Andain, Inc Company Overview 25
5.2.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.3 AngioDynamics Inc Company Overview 26
5.3.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 Avantec Vascular Corporation Company Overview 27
5.4.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 27
5.5 Balch Hill Medical Group Company Overview 28
5.5.1 Balch Hill Medical Group Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 Boston Scientific Corp Company Overview 29
5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 Boston TransTec LLC Company Overview 30
5.7.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 30
5.8 Cardiac Output Technologies, Inc. Company Overview 31
5.8.1 Cardiac Output Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.9 Cardiovascular Systems Inc Company Overview 32
5.9.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 32
5.10 Cordis Corp Company Overview 36
5.10.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 36
5.11 CorNova, Inc. Company Overview 39
5.11.1 CorNova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.12 Delft University of Technology Company Overview 42
5.12.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 42
5.13 Deliverance Ltd. Company Overview 43
5.13.1 Deliverance Ltd. Pipeline Products & Ongoing Clinical Trials Overview 43
5.14 EndoCross Ltd. Company Overview 44
5.14.1 EndoCross Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44
5.15 EP Ltd Company Overview 47
5.15.1 EP Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 Georgia Institute of Technology Company Overview 48
5.16.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 48
5.17 Hadasit Medical Research Services and Development Ltd Company Overview 50
5.17.1 Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
5.18 Harvard University Company Overview 51
5.18.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 51
5.19 iVascular SLU Company Overview 52
5.19.1 iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview 52
5.20 MaRVis Technologies GmbH Company Overview 54
5.20.1 MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 54
5.21 Mayo Clinic Company Overview 55
5.21.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 55
5.22 Mayo Clinic US Company Overview 56
5.22.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 56
5.23 Medical Device Investments, Inc. Company Overview 57
5.23.1 Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.24 Medtronic plc Company Overview 59
5.24.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 59
5.25 Merit Medical Systems Inc Company Overview 60
5.25.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 60
5.26 MicroPort Scientific Corp Company Overview 62
5.26.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 62
5.27 Neovasc Inc Company Overview 64
5.27.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 64
5.28 Nesstent Ltd. Company Overview 65
5.28.1 Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
5.29 NeuroInterventional Therapeutics, Inc. Company Overview 66
5.29.1 NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.30 Nipro Corp Company Overview 68
5.30.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 68
5.31 Northwestern University Company Overview 69
5.31.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 69
5.32 Ohio State University Wexner Medical Center Company Overview 70
5.32.1 Ohio State University Wexner Medical Center Pipeline Products & Ongoing Clinical Trials Overview 70
5.33 Perseus Biomed Ltd. Company Overview 73
5.33.1 Perseus Biomed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
5.34 Pi-Cardia Ltd Company Overview 74
5.34.1 Pi-Cardia Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
5.35 QualiMed Innovative Medizinprodukte GmbH Company Overview 76
5.35.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 76
5.36 Revamp Medical Ltd Company Overview 77
5.36.1 Revamp Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
5.37 Rhythm Solutions Company Overview 80
5.37.1 Rhythm Solutions Pipeline Products & Ongoing Clinical Trials Overview 80
5.38 Sonix Therapeutics Company Overview 81
5.38.1 Sonix Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 81
5.39 Teleflex Inc Company Overview 82
5.39.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 82
5.40 Therix Medical, Inc. (Inactive) Company Overview 83
5.40.1 Therix Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 83
5.41 Topspin Medical Inc. Company Overview 84
5.41.1 Topspin Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 84
5.42 TransCardiac Therapeutics, LLC Company Overview 85
5.42.1 TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 85
5.43 U.S. Stem Cell Inc Company Overview 86
5.43.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 86
5.44 University of California San Diego Company Overview 88
5.44.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 88
5.45 University of California San Francisco Company Overview 89
5.45.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 89
5.46 University of Limerick Company Overview 91
5.46.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 91
5.47 University of Michigan Company Overview 92
5.47.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 92
5.48 University of Montreal Company Overview 93
5.48.1 University of Montreal Pipeline Products & Ongoing Clinical Trials Overview 93
5.49 Vascular Concepts Ltd Company Overview 94
5.49.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
5.50 Volcano Corp Company Overview 95
5.50.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 95
5.51 Voyage Medical (Inactive) Company Overview 96
5.51.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 96
5.52 Weill Cornell Medical College Company Overview 97
5.52.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 97
6 Cardiac Catheters- Recent Developments 98
6.1 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery 98
6.2 Aug 29, 2017: Abbott Issues New Updates for Implanted Cardiac Devices 98
6.3 Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 100
6.4 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 100
6.5 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 103
6.6 Aug 10, 2017: Neovasc Announces Results for the Second Quarter of 2017 103
6.7 Aug 09, 2017: ICU Medical Announces Second Quarter 2017 Results 106
6.8 Aug 09, 2017: U.S. Stem Cell Reports Most Successful Financial Performance in the Company’s History 107
6.9 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 108
6.10 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 108
6.11 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 110
6.12 Aug 03, 2017: Getinge to cooperate with Brazilian authorities on local ongoing investigations 110
6.13 Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results 111
6.14 Aug 02, 2017: Endologix Reports Second Quarter 2017 Financial Results 113
6.15 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 114
6.16 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 114
6.17 Jul 27, 2017: Stryker reports second quarter 2017 results 115
6.18 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 116
6.19 Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year 117
6.20 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 119
6.21 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 121
6.22 Jul 25, 2017: Utah Medical Products Reports Financial Performance for Second Quarter 2017 122
6.23 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 128
6.24 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 128
6.25 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 130
6.26 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 132
6.27 Jul 17, 2017: Getinge appoints Lars Sandstrom as CFO and Member of Getinge Executive Team 134
6.28 Jul 17, 2017: Getinge has replanned the remediation in Hechingen (DE) related to the Consent Decree with FDA and makes a provision of additional SEK 488 M 134
6.29 Jul 17, 2017: Getinge: Interim Report January – June 2017 135
6.30 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 135
6.31 Jul 13, 2017: Kimal prepares for further expansion 136
6.32 Jul 12, 2017: STENTYS: Revenues Of €1.7 Million in the Second Quarter Of 2017 136
6.33 Jul 07, 2017: MPSC New COO Glendy Wang on Board 137
6.34 Jun 28, 2017: Living Values, Aligning Action: Medline Amplifies Commitment to Socially Responsible Business Growth and Impact 137
6.35 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 138
6.36 Jun 24, 2017: Investigation by the Brazilian Administrative Council for Economic Defense comprises two Getinge entities 140
6.37 Jun 22, 2017: Millar Sells Inca Pressure-Volume Loop System to the University of Colorado to Support LVAD Research 140
6.38 Jun 22, 2017: Teleflex’s Vascular Solutions Issues Recall of Venture Catheters 141
6.39 Jun 21, 2017: Vascular Solutions Recalls Venture Catheters due to Excess Material that May Split or Separate During Use 141
6.40 Jun 20, 2017: Medtronic VP and GM Sandra Lesenfants Joins Osprey Board 142
6.41 Jun 20, 2017: Medtronic VP and GM Sandra Lesenfants J oins Osprey Board 142
6.42 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 143
6.43 Jun 09, 2017: Chief Financial Officer leaves Vigmed 143
6.44 May 30, 2017: Interim Report Vigmed Holding 1 January – 31 March 2017 143
6.45 May 26, 2017: Merit Medical Announces Appointment of New Director 144
6.46 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 144
6.47 May 23, 2017: MicroPort Listed as Enterprises Conforming to CSR Standards for Six Consecutive Years 147
6.48 May 18, 2017: Impact of Post-Intervention Fractional Flow Reserve Measurement on Acute PCI Outcomes Investigated in Large Independent Registry 148
6.49 May 17, 2017: Head-to-Head Study Validates Consistent Performance of Microcatheter FFR 149
6.50 May 15, 2017: Millar Grows Adoption of Clinical Pressure-Volume (PV) Loops for Medical Research with Purchase of Inca PV System by the University of Chicago Medicine 150
6.51 May 12, 2017: Abbott Initiates Voluntarily Recall of NC Traveler Coronary Dilatation Catheter 151
6.52 May 10, 2017: ICU Medical Announces First Quarter 2017 Results 152
6.53 May 10, 2017: Neovasc Announces Results for the First Quarter of 2017 152
6.54 May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year 155
6.55 May 04, 2017: Teleflex Reports First Quarter 2017 Results 156
6.56 May 04, 2017: Endologix Reports First Quarter 2017 Financial Results 157
6.57 May 03, 2017: Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results 158
6.58 May 02, 2017: Medline Names New President of Canadian Business 160
7 Appendix 293
7.1 Methodology 293
7.2 About GlobalData 296
7.3 Contact Us 296
7.4 Disclaimer 296

1.1 List of Tables
Table 1: Cardiac Catheters - Pipeline Products by Stage of Development 14
Table 2: Cardiac Catheters - Pipeline Products by Segment 15
Table 3: Cardiac Catheters - Pipeline Products by Territory 16
Table 4: Cardiac Catheters - Pipeline Products by Regulatory Path 17
Table 5: Cardiac Catheters - Pipeline Products by Estimated Approval Date 18
Table 6: Cardiac Catheters - Ongoing Clinical Trials 19
Table 7: Cardiac Catheters Companies - Pipeline Products by Stage of Development 20
Table 8: Cardiac Catheters - Pipeline Products by Stage of Development 22
Table 9: 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 24
Table 10: Sizing Valvuloplasty Conductance Balloon Catheter - Product Status 24
Table 11: Sizing Valvuloplasty Conductance Balloon Catheter - Product Description 24
Table 12: Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 13: Ultrasonic Catheter - Cardiac Catheterization - Product Status 25
Table 14: Ultrasonic Catheter - Cardiac Catheterization - Product Description 25
Table 15: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 16: Coronary Angio Catheter - Product Status 26
Table 17: Coronary Angio Catheter - Product Description 26
Table 18: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 27
Table 19: Specialty Coronary Catheter - Product Status 27
Table 20: Specialty Coronary Catheter - Product Description 27
Table 21: Balch Hill Medical Group Pipeline Products & Ongoing Clinical Trials Overview 28
Table 22: PrecisionThread - Product Status 28
Table 23: PrecisionThread - Product Description 28
Table 24: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29
Table 25: Crossing Catheter - Product Status 29
Table 26: Crossing Catheter - Product Description 29
Table 27: Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 30
Table 28: Viper Catheter - Product Status 30
Table 29: Viper Catheter - Product Description 30
Table 30: Cardiac Output Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 31: Micro-Loop Catheter - Product Status 31
Table 32: Micro-Loop Catheter - Product Description 31
Table 33: Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 34: Diamondback 360 Coronary Orbital Atherectomy System - Product Status 32
Table 35: Diamondback 360 Coronary Orbital Atherectomy System - Product Description 33
Table 36: Cardiovascular Systems Inc - Ongoing Clinical Trials Overview 34
Table 37: Diamondback 360 Coronary Orbital Atherectomy System - Comparison of Orbital Versus Rotational Atherectomy Effects on Coronary Microcirculation in Percutaneous Coronary Intervention (PCI) 35
Table 38: Diamondback 360 Coronary Orbital Atherectomy System - Evaluation of Treatment Strategies for Severe CalcIfic Coronary Arteries: Orbital Atherectomy versus Conventional Angioplasty Technique Prior to Implantation of Drug-eluting Stents: The ECLIPSE Trial 35
Table 39: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 36
Table 40: NOGA Guided Myostar Injection Catheter - Product Status 36
Table 41: NOGA Guided Myostar Injection Catheter - Product Description 36
Table 42: Cordis Corp - Ongoing Clinical Trials Overview 37
Table 43: NOGA Guided Myostar Injection Catheter - A Phase I, Open-label Study of the Effects of Percutaneous Administration of an Extracellular Matrix Hydrogel, VentriGel, Following Myocardial Infarction 38
Table 44: NOGA Guided Myostar Injection Catheter - A Phase I/II, Randomized, Placebo-controlled Study of the Safety and Efficacy of Transendocardial Injection of Autologous Human Cells (Mesenchymal or the Combination of MSC and Cardiac Stem Cells) in Patients with Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction 38
Table 45: CorNova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
Table 46: FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Status 39
Table 47: FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Description 39
Table 48: FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Status 40
Table 49: FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Description 40
Table 50: FiberHalo SRM Stent Delivery Catheter - Product Status 40
Table 51: FiberHalo SRM Stent Delivery Catheter - Product Description 41
Table 52: Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 42
Table 53: Multi-Steerable Catheter - Product Status 42
Table 54: Multi-Steerable Catheter - Product Description 42
Table 55: Deliverance Ltd. Pipeline Products & Ongoing Clinical Trials Overview 43
Table 56: Laparoscopic Braided Sealer And Filler Catheter - Product Status 43
Table 57: Laparoscopic Braided Sealer And Filler Catheter - Product Description 43
Table 58: EndoCross Ltd. Pipeline Products & Ongoing Clinical Trials Overview 44
Table 59: ENABLER-C Catheter System - Product Status 44
Table 60: ENABLER-C Catheter System - Product Description 44
Table 61: EndoCross Ltd. - Ongoing Clinical Trials Overview 45
Table 62: ENABLER-C Catheter System - The ENABLER 3C Study is Investigating the Safety and Efficacy of the ENABLER-C Catheter System in Facilitating Guidewire Advancement Through Chronic Total Occlusions in the Coronary Arteries 46
Table 63: EP Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
Table 64: Laser Based Thermodilution Catheter - Product Status 47
Table 65: Laser Based Thermodilution Catheter - Product Description 47
Table 66: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 48
Table 67: MRI Catheter - Product Status 48
Table 68: MRI Catheter - Product Description 49
Table 69: Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
Table 70: Double Lumen PCI Guiding Catheter - Product Status 50
Table 71: Double Lumen PCI Guiding Catheter - Product Description 50
Table 72: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 51
Table 73: Motion Compensated Catheter System - Product Status 51
Table 74: Motion Compensated Catheter System - Product Description 51
Table 75: iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview 52
Table 76: Navitian Micro Catheter - Product Status 52
Table 77: Navitian Micro Catheter - Product Description 52
Table 78: Sergeant Support Catheter - Product Status 53
Table 79: Sergeant Support Catheter - Product Description 53
Table 80: MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 54
Table 81: MaRVis Catheter - Product Status 54
Table 82: MaRVis Catheter - Product Description 54
Table 83: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 55
Table 84: Acoustic Catheter - Product Status 55
Table 85: Acoustic Catheter - Product Description 55
Table 86: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 56
Table 87: Aortic Valve Guide Catheter - Product Status 56
Table 88: Aortic Valve Guide Catheter - Product Description 56
Table 89: Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
Table 90: Cardiac/Carotid Aspirating Balloon Catheter - Product Status 57
Table 91: Cardiac/Carotid Aspirating Balloon Catheter - Product Description 57
Table 92: Ostial Stent Placement Catheter - Product Status 58
Table 93: Ostial Stent Placement Catheter - Product Description 58
Table 94: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 59
Table 95: Low Profile FFR Micro-catheter - Product Status 59
Table 96: Low Profile FFR Micro-catheter - Product Description 59
Table 97: Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 98: Crossing Support Guide Catheter - Product Status 60
Table 99: Crossing Support Guide Catheter - Product Description 60
Table 100: Lamsano - Product Status 61
Table 101: Lamsano - Product Description 61
Table 102: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 62
Table 103: Catheter - Coronary Ischemia - Product Status 62
Table 104: Catheter - Coronary Ischemia - Product Description 62
Table 105: Intramyocardial Injection Catheter - Product Status 63
Table 106: Intramyocardial Injection Catheter - Product Description 63
Table 107: Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 108: Ostial Flare - Product Status 64
Table 109: Ostial Flare - Product Description 64
Table 110: Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
Table 111: NesStent's catheter - Product Status 65
Table 112: NesStent's catheter - Product Description 65
Table 113: NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
Table 114: Catheter - Carotid Stenting - Product Status 66
Table 115: Catheter - Carotid Stenting - Product Description 66
Table 116: DVT Intervention System - Product Status 67
Table 117: DVT Intervention System - Product Description 67
Table 118: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 68
Table 119: Micro Catheter - Product Status 68
Table 120: Micro Catheter - Product Description 68
Table 121: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 69
Table 122: Triple Balloon Occlusion/ Infusion Catheter - Product Status 69
Table 123: Triple Balloon Occlusion/ Infusion Catheter - Product Description 69
Table 124: Ohio State University Wexner Medical Center Pipeline Products & Ongoing Clinical Trials Overview 70
Table 125: Cardiovascular Catheter - Congestive Heart Failure - Product Status 70
Table 126: Cardiovascular Catheter - Congestive Heart Failure - Product Description 70
Table 127: Ohio State University Wexner Medical Center - Ongoing Clinical Trials Overview 71
Table 128: Cardiovascular Catheter - Congestive Heart Failure - Safety and Feasibility of Cardiovascular Catheter in Treatment of Patients with Congestive Heart Failure 72
Table 129: Perseus Biomed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
Table 130: Intravascular Catheter - Chronic Disease - Product Status 73
Table 131: Intravascular Catheter - Chronic Disease - Product Description 73
Table 132: Pi-Cardia Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
Table 133: LeafLex - Product Status 74
Table 134: LeafLex - Product Description 74
Table 135: Second Generation Leaflex Performer Catheter - Product Status 75
Table 136: Second Generation Leaflex Performer Catheter - Product Description 75
Table 137: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 76
Table 138: Biodegradable Catheter - Product Status 76
Table 139: Biodegradable Catheter - Product Description 76
Table 140: Revamp Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
Table 141: Doraya Catheter - Product Status 77
Table 142: Doraya Catheter - Product Description 77
Table 143: Revamp Medical Ltd - Ongoing Clinical Trials Overview 78
Table 144: Doraya Catheter - First in Human Study of the Doraya Catheter for the Treatment of AHF Patients 79
Table 145: Rhythm Solutions Pipeline Products & Ongoing Clinical Trials Overview 80
Table 146: Cardiovascular Catheter - Gene Therapy - Product Status 80
Table 147: Cardiovascular Catheter - Gene Therapy - Product Description 80
Table 148: Sonix Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 81
Table 149: Percutaneous Ultrasonic Drug Delivery System - Product Status 81
Table 150: Percutaneous Ultrasonic Drug Delivery System - Product Description 81
Table 151: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 82
Table 152: TrapLiner Catheter - Product Status 82
Table 153: TrapLiner Catheter - Product Description 82
Table 154: Therix Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 83
Table 155: Cardiac Diagnostic Catheter - Product Status 83
Table 156: Cardiac Diagnostic Catheter - Product Description 83
Table 157: Topspin Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 84
Table 158: IntraVascular MRI catheter - Product Status 84
Table 159: IntraVascular MRI catheter - Product Description 84
Table 160: TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 85
Table 161: EndoCardiac Navigator - Product Status 85
Table 162: EndoCardiac Navigator - Product Description 85
Table 163: U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview 86
Table 164: MyoCath - Product Status 86
Table 165: MyoCath - Product Description 86
Table 166: MyoCath II - Product Status 87
Table 167: MyoCath II - Product Description 87
Table 168: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 88
Table 169: Peripheral Venous Catheter/Cannula - Product Status 88
Table 170: Peripheral Venous Catheter/Cannula - Product Description 88
Table 171: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 89
Table 172: Cardiac Catheter - Product Status 89
Table 173: Cardiac Catheter - Product Description 89
Table 174: Delivery Catheter - Product Status 90
Table 175: Delivery Catheter - Product Description 90
Table 176: University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 91
Table 177: Pre-Hydrate Catheter - Product Status 91
Table 178: Pre-Hydrate Catheter - Product Description 91
Table 179: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 92
Table 180: Integrated Dual Lumen Catheter - Product Status 92
Table 181: Integrated Dual Lumen Catheter - Product Description 92
Table 182: University of Montreal Pipeline Products & Ongoing Clinical Trials Overview 93
Table 183: Multifunction Catheter - Product Status 93
Table 184: Multifunction Catheter - Product Description 93
Table 185: Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview 94
Table 186: Accura - Product Status 94
Table 187: Accura - Product Description 94
Table 188: Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 95
Table 189: Forward Looking ICE - Product Status 95
Table 190: Forward Looking ICE - Product Description 95
Table 191: Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 96
Table 192: IRIS Transseptal Catheter - Product Status 96
Table 193: IRIS Transseptal Catheter - Product Description 96
Table 194: Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 97
Table 195: Zone Isolation and Bypass System - Product Status 97
Table 196: Zone Isolation and Bypass System - Product Description 97
Table 197: Glossary 295

1.2 List of Figures
Figure 1: Cardiac Catheters - Pipeline Products by Stage of Development 14
Figure 2: Cardiac Catheters - Pipeline Products by Segment 15
Figure 3: Cardiac Catheters - Pipeline Products by Territory 16
Figure 4: Cardiac Catheters - Pipeline Products by Regulatory Path 17
Figure 5: Cardiac Catheters - Pipeline Products by Estimated Approval Date 18
Figure 6: Cardiac Catheters - Ongoing Clinical Trials 19

【掲載企業】

3DT Holdings, LLC
Andain, Inc
AngioDynamics Inc
Avantec Vascular Corporation
Balch Hill Medical Group
Boston Scientific Corp
Boston TransTec LLC
Cardiac Output Technologies, Inc.
Cardiovascular Systems Inc
Cordis Corp
CorNova, Inc.
Delft University of Technology
Deliverance Ltd.
EndoCross Ltd.
EP Ltd
Georgia Institute of Technology
Hadasit Medical Research Services and Development Ltd
Harvard University
iVascular SLU
MaRVis Technologies GmbH
Mayo Clinic
Mayo Clinic US
Medical Device Investments, Inc.
Medtronic plc
Merit Medical Systems Inc
MicroPort Scientific Corp
Neovasc Inc
Nesstent Ltd.
NeuroInterventional Therapeutics, Inc.
Nipro Corp
Northwestern University
Ohio State University Wexner Medical Center
Perseus Biomed Ltd.
Pi-Cardia Ltd
QualiMed Innovative Medizinprodukte GmbH
Revamp Medical Ltd
Rhythm Solutions
Sonix Therapeutics
Teleflex Inc
Therix Medical, Inc.
Topspin Medical Inc.
TransCardiac Therapeutics, LLC
U.S. Stem Cell Inc
University of California San Diego
University of California San Francisco
University of Limerick
University of Michigan
University of Montreal
Vascular Concepts Ltd
Volcano Corp
Voyage Medical
Weill Cornell Medical College

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 心臓カテーテル:医療機器パイプライン分析2017(Cardiac Catheters - Medical Devices Pipeline Assessment, 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆